Interview: Will Aberdeen Alzheimer’s drug be approved by the end of the year? We can only hope

TauRx says its oral Alzheimer’s treatment could be approaching a defining moment. For the Aberdeen firm, the stakes are huge — but in dementia research, hope is never simple.